/SHPH
SHPH Stock - Shuttle Pharmaceuticals Holdings, Inc.
Healthcare|Drug Manufacturers - Specialty & GenericNASDAQ
$1.72+1.18%
+$0.02 (+1.18%) • Dec 19
54
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.0
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.97
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $1.89
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for SHPH
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$1.70 – $1.74
TARGET (TP)$1.98
STOP LOSS$1.58
RISK/REWARD1:1.9
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta0.56
52W High$25.25
52W Low$1.26
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | N/A | N/A | N/A | N/A | N/A |
| Gross Profit | N/A | N/A | $-5,972 | $-60,834 | $-54,951 |
| Gross Margin | N/A | N/A | N/A | N/A | N/A |
| Operating Income | $-7,696,170 | $-5,892,382 | $-2,343,826 | $-1,742,992 | $-509,522 |
| Net Income | $-9,144,797 | $-6,592,723 | $-4,996,069 | $-1,152,134 | $-805,732 |
| Net Margin | N/A | N/A | N/A | N/A | N/A |
| EPS | $-885.73 | $-0.41 | $-0.30 | $-0.09 | $-0.07 |
Company Overview
Shuttle Pharmaceuticals Holdings, Inc., through its subsidiary, Shuttle Pharmaceuticals, Inc., focuses on the discovery, development, and commercialization of drugs for sensitizing cancers to radiation therapy. Its products in clinical stage include Ropidoxuridine, an oral halogenated pyrimidine to treat patients with brain tumors and soft tissue sarcomas; and Doranidazole, an injectable hypoxic cell radiation sensitizer for treatment of pancreatic, lung, and liver cancers. The company was founded in 2012 and is based in Rockville, Maryland.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
SHPHBeat Rate
0%
Last 0 quarters
Avg Surprise
+0%
EPS vs Estimate
Beats / Misses
0/0
Last 12 quarters
Latest EPS
$-1.05
Q4 2025
EPS Surprise History
Q1 24
No data
Q2 24
No data
Q3 24
No data
Q4 24
No data
Q1 25
No data
Q2 25
No data
Q3 25
No data
Q4 25
No data
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q4 2025 | Nov 13, 2025 | — | $-1.05 | — | — |
Q3 2025 | Aug 12, 2025 | — | $-3.29 | — | — |
Q2 2025 | May 8, 2025 | — | $-7.50 | — | — |
Q1 2025 | Mar 20, 2025 | — | $-0.80 | — | — |
Q4 2024 | Nov 13, 2024 | — | $-39.75 | — | — |
Q3 2024 | Sep 3, 2024 | — | $-24.00 | — | — |
Q2 2024 | May 13, 2024 | — | $-20.00 | — | — |
Q1 2024 | Mar 21, 2024 | — | $-20.00 | — | — |
Q4 2023 | Nov 13, 2023 | — | $-0.11 | — | — |
Q3 2023 | Aug 14, 2023 | — | $-0.15 | — | — |
Q2 2023 | May 25, 2023 | — | $0.02 | — | — |
Q1 2023 | Mar 15, 2023 | — | $-0.06 | — | — |
Q4 2022 | Nov 14, 2022 | — | $-0.10 | — | — |
Q2 2022 | Jun 30, 2022 | — | $-0.06 | — | — |
Q1 2022 | Mar 31, 2022 | — | $-0.05 | — | — |
Q4 2021 | Dec 31, 2021 | — | $-0.03 | — | — |
Q3 2021 | Sep 30, 2021 | — | $-0.02 | — | — |
Q2 2021 | Jun 30, 2021 | — | $-0.03 | — | — |
Q1 2021 | Mar 31, 2021 | — | $-0.01 | — | — |
Latest News
Shuttle Pharmaceuticals Q3 EPS $(1.05) Up From $(39.75) YoY
➖ NeutralBenzinga•Nov 13, 2025, 10:35 PM
Shuttle Pharmaceuticals Announces $2.5M Private Placement At $4.00 Per Share, Priced Above Market Under Nasdaq Rules
📈 PositiveBenzinga•Nov 3, 2025, 12:27 PM
Shuttle Pharmaceuticals Announces Above-the-Market $2.5M Private Placement At Effective Purchase Price Of $4/Share
📈 PositiveBenzinga•Nov 3, 2025, 12:03 PM
Shuttle Pharmaceuticals Holdings shares are trading higher after the company announced it will acquire Molecule's assets and liabilities for $10 million.
📈 PositiveBenzinga•Oct 21, 2025, 08:13 PM
Shuttle Pharmaceuticals Enters Binding Term Sheet With 1542770 BC To Acquire All Molecule's Assets And Liabilities For $10M
📈 PositiveBenzinga•Oct 21, 2025, 08:12 PM
Shuttle Pharmaceuticals Shares Halted On Circuit Breaker To The Upside, Stock Now Up 6.09%
📈 PositiveBenzinga•Oct 10, 2025, 02:57 PM
Shuttle Pharma Executes Non-Binding LOI To Acquire Molecule.ai And Its Platform For $10M In Combination Of Cash And Common Shares
➖ NeutralBenzinga•Oct 10, 2025, 02:23 PM
Shuttle Pharmaceuticals Announces Non-Binding LOI To Purchase Molecule.ai For $10M
➖ NeutralBenzinga•Oct 9, 2025, 08:19 PM
Shuttle Pharmaceuticals announces 25-for-1 reverse stock split; shares down over 26%
📉 NegativeSeeking Alpha•Jun 12, 2025, 01:06 PM
Frequently Asked Questions about SHPH
What is SHPH's current stock price?
Shuttle Pharmaceuticals Holdings, Inc. (SHPH) is currently trading at $1.72 per share. The stock has moved +1.18% today.
What is the analyst price target for SHPH?
No analyst price targets are currently available for this stock.
What sector is Shuttle Pharmaceuticals Holdings, Inc. in?
Shuttle Pharmaceuticals Holdings, Inc. operates in the Healthcare sector, specifically within the Drug Manufacturers - Specialty & Generic industry. The company is traded on the NASDAQ exchange.
What is SHPH's market cap?
Shuttle Pharmaceuticals Holdings, Inc. has a market capitalization of $0.00 billion, making it a small-cap company.
Does SHPH pay dividends?
No, Shuttle Pharmaceuticals Holdings, Inc. does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorAKAN
Akanda Corp.
$0.61
Mkt Cap: $0.0B
BBLG
Bone Biologics Corporation
$1.83
Mkt Cap: $0.0B
BIVI
BioVie Inc.
$1.41
Mkt Cap: $0.0B
HSCS
HeartSciences Inc.
$2.36
Mkt Cap: $0.0B
IMCC
IM Cannabis Corp.
$1.56
Mkt Cap: $0.0B
ISPC
iSpecimen Inc.
$0.37
Mkt Cap: $0.0B
MSPR
MSP Recovery, Inc.
$0.20
Mkt Cap: $0.0B
RDHL
RedHill Biopharma Ltd.
$1.18
Mkt Cap: $0.0B
TOVX
Theriva Biologics, Inc.
$0.19
Mkt Cap: $0.0B
UPC
Universe Pharmaceuticals Inc.
$3.73
Mkt Cap: $0.0B
Explore stocks similar to SHPH for comparison